Potent and selective recognition and modulation of disease-relevant RNAs remain a daunting challenge. We previously examined the utility of the U1A N-terminal RNA recognition motif as a scaffold for tailoring new RNA hairpin recognition and showed that as few as one or two mutations can result in moderate affinity (low μM dissociation constant) for the human immunodeficiency virus (HIV) trans-activation response element (TAR) RNA, an RNA hairpin controlling transcription of the human immunodeficiency virus (HIV) genome. Here, we use yeast display and saturation mutagenesis of established RNA-binding regions in U1A to identify new synthetic proteins that potently and selectively bind TAR RNA. Our best candidate has truly altered, not simply ...
Small molecules that bind their biological receptors with high affinity and selectivity can be isola...
Antiretroviral therapy to treat AIDS uses molecules that target the reverse transcriptase and protea...
A major problem associated with anti-HIV-1 treatment is rapid emergence of drug-resistant strains. A...
A multitude of RNA hairpins are directly implicated in human disease. Many of these RNAs are potenti...
Natural and lab-evolved proteins often recognize their RNA partners with exquisite affinity. Structu...
International audienceThe human immunodeficiency virus type-1 (HIV-1) Tat protein stimulates transcr...
International audienceThe human immunodeficiency virus type-1 (HIV-1) Tat protein stimulates transcr...
Small molecules that bind to RNA potently and specifically are relatively rare. The study of molecul...
International audienceThe human immunodeficiency virus type-1 (HIV-1) Tat protein stimulates transcr...
AbstractBackground: In lentiviruses such as human immunodeficiency virus (HIV) and bovine immunodefi...
The transactivation responsive (TAR) RNA is the 5'-leader sequence of the HIV-1 mRNA genome and inte...
Small molecules that bind their biological receptors with high affinity and selectivity can be isola...
A target RNA/DNA-specific nuclease could be con-structed if a specific RNA/DNA binding domain allow-...
Proteolytically produced carboxyl-terminal fragments of the human immunodeficiency virus type-1 (HIV...
Proteolytically produced carboxyl-terminal fragments of the human immunodeficiency virus type-1 (HIV...
Small molecules that bind their biological receptors with high affinity and selectivity can be isola...
Antiretroviral therapy to treat AIDS uses molecules that target the reverse transcriptase and protea...
A major problem associated with anti-HIV-1 treatment is rapid emergence of drug-resistant strains. A...
A multitude of RNA hairpins are directly implicated in human disease. Many of these RNAs are potenti...
Natural and lab-evolved proteins often recognize their RNA partners with exquisite affinity. Structu...
International audienceThe human immunodeficiency virus type-1 (HIV-1) Tat protein stimulates transcr...
International audienceThe human immunodeficiency virus type-1 (HIV-1) Tat protein stimulates transcr...
Small molecules that bind to RNA potently and specifically are relatively rare. The study of molecul...
International audienceThe human immunodeficiency virus type-1 (HIV-1) Tat protein stimulates transcr...
AbstractBackground: In lentiviruses such as human immunodeficiency virus (HIV) and bovine immunodefi...
The transactivation responsive (TAR) RNA is the 5'-leader sequence of the HIV-1 mRNA genome and inte...
Small molecules that bind their biological receptors with high affinity and selectivity can be isola...
A target RNA/DNA-specific nuclease could be con-structed if a specific RNA/DNA binding domain allow-...
Proteolytically produced carboxyl-terminal fragments of the human immunodeficiency virus type-1 (HIV...
Proteolytically produced carboxyl-terminal fragments of the human immunodeficiency virus type-1 (HIV...
Small molecules that bind their biological receptors with high affinity and selectivity can be isola...
Antiretroviral therapy to treat AIDS uses molecules that target the reverse transcriptase and protea...
A major problem associated with anti-HIV-1 treatment is rapid emergence of drug-resistant strains. A...